Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) -21.6327.368.439.274.87

What is the latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS is -21.63 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar2024-21.63
Mar202327.36
Mar20228.43
Mar20219.27
Mar20204.87

How is Price to Cash Earnings (PCE) of GLENMARK PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 -21.63
Negative
Mar2023 27.36
224.56
Mar2022 8.43
-9.06
Mar2021 9.27
90.35
Mar2020 4.87 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹43,540.6 Cr 1.5% 17.6% 54.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,706.0 Cr 2.3% 11.7% 5.1% Stock Analytics
DIVIS LABORATORIES ₹152,946.0 Cr -1.6% 4% 58.7% Stock Analytics
CIPLA ₹120,751.0 Cr 0.8% 6.2% -2.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,988.0 Cr 0.7% 9.8% 19.8% Stock Analytics
DR REDDYS LABORATORIES ₹96,066.7 Cr -1% 2.8% -8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.5%

17.6%

54.5%

SENSEX

-1.3%

4.2%

3.6%


You may also like the below Video Courses